发明名称 |
Inhibitor of human myeloid leukemia based on N-(4-(5-(pyridin-2-yl)-4,5-dihydro-1H-pyrazol-3-yl)phenyl)-2-(pyridin-2-ylmethylen)-hydrazinecarbothioamide |
摘要 |
The invention relates to organic chemistry, namely to the synthesis of biologically active compounds from the group of hydrazinecarbothioamides with heterocyclic nuclei which can be used for prevention and treatment of human myeloid leukemia.Summary of the invention consists in that as an inhibitor of human myeloid leukemia (HL-60 cells) is proposed a new compound N-(4-(5-(pyridin-2-yl)-4,5-dihydro-1H-pyrazol-3-yl)phenyl)-2-(pyridin-2-ylmethylen)-hydrazinecarbothioamide with the formula:The claimed compound possesses inhibitory properties of human myeloid leukemia. |
申请公布号 |
MD4215(C1) |
申请公布日期 |
2013.11.30 |
申请号 |
MD20120000059 |
申请日期 |
2012.07.09 |
申请人 |
UNIVERSITATEA DE STAT DIN MOLDOVA |
发明人 |
BARBA NICANOR;GULEA AURELIAN;POPUSOI ANA;JALBA ANGELA |
分类号 |
C07C251/82;A61K31/33;A61P35/02;C07C337/08;C07D231/06 |
主分类号 |
C07C251/82 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|